brand brand
Collapse

Modality Type - T-cell Therapy Market Statistics

The global modality type t-cell therapy market size was valued at US$ 4,692.0 million in 2020 and is estimated to grow at a compound annual growth rate (CAGR) of 18.1% from 2021 to 2028.

Global t cell therapy market statistics, by modality type, 2018-2028 (USD Million)

  • Select file type

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Global t cell therapy market statistics, by modality type, 2018-2028 (USD Million)
Unlock Premium

Related Statistics

Global t cell therapy market statistics, by indication, 2018-2028 (USD Million)

Global t cell therapy market statistics, by hematologic malignancies, 2018-2028 (USD Million)

Global t cell therapy market statistics, by solid tumors, 2018-2028 (USD Million)

Global t cell therapy market statistics, by therapy type, 2018-2028 (USD Million)

Tumor infiltrating lymphocytes (til)-based: Global t-cell therapy market statistics, 2018-2028 (USD Million)

Lymphoma: Global t-cell therapy market statistics, 2018-2028 (USD Million)

T cell receptor (tcr)-based: Global t-cell therapy market statistics, 2018-2028 (USD Million)

Commercialized: Global t-cell therapy market statistics, 2018-2028 (USD Million)

Melanoma: Global t-cell therapy market statistics, 2018-2028 (USD Million)

Liver cancer: Global t-cell therapy market statistics, 2018-2028 (USD Million)

Research: Global t-cell therapy market statistics, 2018-2028 (USD Million)

Car t-cell therapy: Global t-cell therapy market statistics, 2018-2028 (USD Million)

Leukemia: Global t-cell therapy market statistics, 2018-2028 (USD Million)

Myeloma: Global t-cell therapy market statistics, 2018-2028 (USD Million)

Brain & central nervous system: Global t-cell therapy market statistics, 2018-2028 (USD Million)

T-cell Therapy Market Scope

T-cell therapy market segmentation & scope
Modality Type
Research
Commercialized
Therapy Type
T Cell Receptor (TCR)-based
CAR T-cell Therapy
Tumor Infiltrating Lymphocytes (TIL)-based
Indication
Hematologic Malignancies
Lymphoma
Myeloma
Leukemia
Others
Solid Tumors
Melanoma
Brain & Central Nervous System
Liver Cancer
Others
Regions
Latin America
Europe
North America
Middle East & Africa
Asia Pacific
Countries
U.S.
Canada
Germany
UK
China
Japan
Brazil
South Africa
report
T-cell Therapy Market Outlook
  • PDF
  • HTML
  • PPT
  • -
Everything on T-cell Therapy Market Outlook in one document: edited and divided into chapters, including detailed references.

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more